Given that FSHD is a pathology characterized by elevated intracellular ROS [34], inhibited regeneration [54] and inflammation [50], further investigation of HMGB1 in FSHD is ongoing. This evidence concerns the gene HMGB1 and facioscapulohumeral muscular dystrophy.